Regeneron PharmaceuticalsvsThermo Fisher Scientific

REGN and TMO stock compared: price, dividend, valuation and results, from SEC filings.

REGN

Regeneron Pharmaceuticals, Inc.

$955.47

Value $99.9B

+0.45%
REGN's page

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Regeneron Pharmaceuticals (REGN) has a market value of $99.9B and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, REGN moved +40.9% and TMO +19.5%. The P/E is 20.8 for REGN and 36.8 for TMO. Dividend yield: REGN 0.39%, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    REGN$99.9B

    TMO$260B

    TMO is 2.6 times REGN

  • Revenue, 12 months

    REGN$16.9B

    TMO$47.4B

    TMO is 2.8 times REGN

  • Net income, 12 months

    REGN$4.8B

    TMO$7.1B

    TMO is 1.5 times REGN

  • Operating margin

    REGN28.8%

    TMO17.9%

    10.9 points apart

  • ROIC

    REGN12.2%

    TMO8.2%

    4.0 points apart

  • P/E

    REGN20.8

    TMO36.8

    TMO is 1.8 times REGN

  • Dividend yield

    REGN0.4%

    TMO0.3%

    0.1 points apart

  • 5-year return

    REGN+52.8%

    TMO+11.8%

    41.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

REGN+52.8%

TMO+11.8%

10015020222023202420252026
Returns by period
PeriodREGNWith dividendsTMOWith dividends
1 year since November 12, 2025+40.9%Price +40.2%+19.5%Price +19.1%
3 years since November 13, 2023+21.0%+6.6% a yearPrice +19.9%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021+52.8%+8.8% a yearPrice +51.4%+11.8%+2.3% a yearPrice +10.2%
10 years since November 15, 2016+125.0%+8.4% a yearPrice +122.9%+384.5%+17.1% a yearPrice +371.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

REGNRegeneron PharmaceuticalsTMOThermo Fisher Scientific

Valuation

REGNTMO
Valuation
Price$955.47$700.22
Market value$99.9B$260B
Enterprise value (EV)$93.3B$295B
P/E20.836.8
P/E, 5-year median18.632.7
P/B3.04.8
EV/EBIT19.234.9
Free cash flow yield3.8%2.9%

Results and growth

REGNTMO
Results and growth
Revenue, 12 months$16.9B$47.4B
Net income, 12 months$4.8B$7.1B
Free cash flow, 12 months$3.8B$7.6B
Earnings per share, 12 months$45.30$18.96
Revenue growth, year on year1.0%3.9%
Revenue growth a year, past+11.0%over 5 years+6.7%over 5 years
EPS growth a year, past+6.3%over 5 years+2.1%over 5 years

Margins and returns on capital

REGNTMO
Margins and returns on capital
Gross margin––
Operating margin28.8%17.9%
Net margin28.5%14.9%
ROIC12.2%8.2%
ROE15.2%13.4%

Balance sheet

REGNTMO
Balance sheet
Cash$9.3B$6.1B
Total debt$2.7B$41.4B
Net debt / EBITDA-1.23.7
Interest cover104.2×5.5×

Dividends and buybacks

REGNTMO
Dividends and buybacks
Dividend yield0.4%0.3%
Dividend per share, 12 months$3.70$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield3.4%1.2%
Shareholder yield3.8%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: REGN or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Regeneron Pharmaceuticals or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 2.6 times Regeneron Pharmaceuticals ($99.9B), at today's prices.

How did REGN and TMO stock do over the last 10 years?

Since November 15, 2016, REGN's price moved +122.9% and TMO's +371.0%. With dividends: REGN +125.0% (+8.4% a year), TMO +384.5% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, REGN or TMO?

The dividend yield at today's price is 0.39% for Regeneron Pharmaceuticals and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid $3.70 and $1.84 per share.

What is the P/E of REGN and TMO?

At today's price, the P/E is 20.8 for REGN and 36.8 for TMO. The median of the last five years was 18.6 and 32.7, which shows where each stands against its own past.

Which has the higher profit margins, Regeneron Pharmaceuticals or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 28.5% for Regeneron Pharmaceuticals and 14.9% for Thermo Fisher Scientific, and the operating margin 28.8% and 17.9%. Revenue was $16.9B and $47.4B.

Which is the better investment, Regeneron Pharmaceuticals or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.